San Diego
San Diego
Art Dykhuis focuses his practice on complex patent litigation. He counsels clients in various technology areas, including pharmaceuticals, medical devices, electronics, software and mechanical devices. He has experience in district court, at the USPTO before the PTAB, and before the Federal Circuit. Art handles all aspects of litigation, including pre-trial investigations, initiating litigation, discovery, taking and defending depositions, working with experts and trial.
Results
- Defended a pharmaceutical manufacturer through trial, where the asserted patent on an injection device was found invalid and not infringed (Sanofi-Aventis v. Mylan (D.N.J.))*
- Brought litigation relating to PCR technology to offset separate pending litigation brought by the defendant, resulting in a favorable settlement*
- Represented a leading network operator against claims of patent infringement relating to the encapsulation and carrying of various types of data across the transport network*
- Defended a smartphone manufacturer from assertion of nine patents relating to 3G and WiFi technologies*
Recognitions
- Best Lawyers: Ones to Watch in America, Intellectual Property Law, 2026
- Managing Intellectual Property, Rising Star, 2024
- California Lawyers Association Wiley W. Manuel Award for pro bono service, 2020
Capabilities and Industries
Regional Markets
Credentials
Education
- Northwestern Pritzker School of Law, JD, magna cum laude
- Calvin College, BSE, Concentration in Mechanical Engineering, with honors
Admissions
- California
- Texas
Courts / Agencies
- US Court of Appeals for the Federal Circuit
- US Court of Appeals for the Ninth Circuit
- US Court of Appeals for Veterans Claims
- US District Court for the Northern District of California
- US District Court for the Central District of California
- US District Court for the Southern District of California
- US District Court for the Eastern District of Texas
- US District Court for the Northern District of Texas
- US Patent and Trademark Office
Art Dykhuis’s
Insights, News & Events
Insights, News & Events
